期刊文献+

我院2013年门诊基本药物使用情况调查分析 被引量:1

Investigation and Analysis of the Use of National Essential Medicines in Outpatient Department of Our Hospital in 2013
原文传递
导出
摘要 目的:了解我院门诊基本药物使用状况,促进基本药物在我院的合理使用。方法:比较我院(眼耳鼻喉专科医院)2013年门诊各科及全院上、下半年基本药物处方品种占比和费用占比;对眼科、耳鼻喉科两个主要科室处方品种占比居前列的药品进行排序,并对4个季度的排序进行比较。结果:随着2012年版《国家基本药物目录》的施行,2013年下半年全院门诊基本药物处方品种占比和费用占比较上半年均显著上升(P<0.01)。眼科2013下半年基本药物处方品种占比和费用占比较上半年均有显著上升(P<0.01),处方品种占比前20位中收载入2012年版《国家基本药物目录》的有2种,收载入2010版上海市增补目录的有3种。耳鼻喉科2013下半年基本药物处方品种占比较上半年显著下降(P<0.01),费用占比显著上升(P<0.01),处方品种占比前20位中收载入2012年版《国家基本药物目录》的有2种,收载入2010版上海市增补目录的有3种。结论:我院基本药物的处方品种占比和费用占比呈上升趋势,但非基本药物仍占主导地位,基本药物的使用率有待提高。基本药物目录收载的眼耳鼻喉科等专科药品品种不足、剂型单一,未来基本药物目录的调整还需要更多考虑专科医院的用药特点。 OBJECTIVE: To understand the situation of essential medicines and promote their rational use in our hospital. METHODS: The prescription variety and cost percentages of essential medicines in outpatient department in the two halves years of 2013 in our hospital (eye and ENT specialized hospitals) were compared; the medicines with forefront prescription kind percent- ages in eye and ENT departments were sorted and rankings in 4 quarters were compared. RESULTS : After the approval of the Na- tional Essential Medicine List (2012 edition), compared with the first half year of 2013, prescription variety and cost percentages of essential medicines in outpatient department in the second half year were significantly increased (P〈0.01). Prescription variety and cost percentages of essential medicines in eye department in the second half year were significantly increased(P〈0.01), in the top 20 prescription variety, totally 2 kinds were contained by the list 2012 edition and 3 were contained by the supplementary list of Shanghai (2012 edition). Compared with the first half year of 2013, prescription variety and cost percentages of essential medi- cines in ENT department in the second half year were significantly decreased (P〈0.01), the cost percentage was significantly in- creased(P〈0.01), in the top 20 prescription variety, totally 2 kinds were contained by the list 2012 edition and 3 were contained by the supplementary list of Shanghai (2012 edition). CONCLUSIONS: The prescription variety and cost percentages of essential medicines in our hospital show increase trend. Nevertheless, the non-essential medicines are still dominant and further improvement of essential medicines is still needed. Medicine variety and dosage forms of eye in ENT department are insufficient concluded in Es- sential Medicine List. Further adjustment of Essential Medicine List still needs more consideration for the medication characteristics in specialized hospital.
出处 《中国药房》 CAS 北大核心 2015年第27期3763-3766,共4页 China Pharmacy
关键词 专科医院 门诊 基本药物 处方品种占比 费用占比 排序 分析 Specialized hospital Outpatient Essential medicine Percentage of prescription variety Percentage of cost Rank Analysis
  • 相关文献

参考文献8

二级参考文献62

  • 1胡美君.爱丽滴眼液治疗角膜上皮缺损的临床观察[J].临床眼科杂志,2006,14(1):64-65. 被引量:3
  • 2唐细兰,黄楚龙,叶成添.人工泪液的药理及临床使用情况分析[J].中国生化药物杂志,2006,27(2):124-126. 被引量:12
  • 3Scadding GK, Durham SIR, Mirakian R, et al. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin ExpAIlergy, 2008, 38: 260-275.
  • 4Fokkens W, Lund V, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl, 2007, (20): 1-136.
  • 5上海市卫生局,上海市发展和改革委员会(物价局),上海市经济和信息化委员会,等.关于印发《上海市实施国家基本药物制度工作方案(试行)》的通知[EB/OL].http://wsj.sh.gov.cn/website/b159582.shtml,2010-03-06.
  • 6李凤鸣.眼科全书(中册)[M].北京:人民卫生出版社,1997.2305-2306.
  • 7Hindmarch I,Johnson S,Meadows R,et al.The acute and subchronic effects of levocetirizine,cetrizine,loratadine,promethazine and placebo on cognitive function,psychomotor performance and weal and flare.Current Med Res Opin,2001,17:241-255.
  • 8Gandon J M,Allain H.Lack of effect of single and repeated doses of levocetirizine,a new antihistamine drug,on cognitive and psychomotor functions in healthy volunteers.Br J Clin Pharmacol,2002,54:51-58.
  • 9Volkert E R,Verster J C.Acute and subchronic CNS effects of a new generation antihistamine,levocetirizine,and level of activity in the weal and flare model.Methods Find Exp Clin Pharmacol,2004,26(Suppl 2):3-7.
  • 10Day J H,Ellis A K,Rafeiro E.Levocetirizine:a new selective H1 receptor antagonist for use in allergic disorders.Drugs Today,2004,40:415-421.

共引文献50

同被引文献11

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部